Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aung Naing

Showing results (161-170 of 397) with videos related to

Pageof 40
Sort By:
Investigational New Drugs|January 28, 2020
A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinomaDavid C Smith, Matthias Kroiss, Electron Kebebew, et al.
Cancers|August 23, 2020
Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and ParagangliomasCamilo Jimenez, Vivek Subbiah, Bettzy Stephen, et al.
Journal for Immunotherapy of Cancer|January 17, 2025
Phase I study of BMS-986299, an NLRP3 agonist, as monotherapy and in combination with nivolumab and ipilimumab in patients with advanced solid tumorsBlessie E Nelson, Shaun O'Brien, Rahul A Sheth, et al.
The Oncologist|January 25, 2021
Pembrolizumab in Patients with Advanced Metastatic Germ Cell TumorsApostolia-Maria Tsimberidou, Henry Hiep Vo, Vivek Subbiah, et al.
Oncotarget|June 27, 2013
Revisiting clinical trials using EGFR inhibitor-based regimens in patients with advanced non-small cell lung cancer: a retrospective analysis of an MD Anderson Cancer Center phase I populationJennifer Wheler, Gerald Falchook, Apostolia M Tsimberidou, et al.
Journal of Gastrointestinal Cancer|April 29, 2023
Utility of Established Prognostic Scoring Systems for Patients with Advanced Pancreatic Adenocarcinoma Enrolled in Immunotherapy-Based Early-Phase Clinical TrialsRishi Surana, Graciela Nogueras Gonzalez, Jane Rogers, et al.
Cancers|August 12, 2022
Clinical Outcomes of Patients with Recurrent Microsatellite-Stable Endometrial Cancer in Early-Phase Immunotherapy Clinical TrialsJeffrey A How, Amir A Jazaeri, Siqing Fu, et al.
The Oncologist|March 27, 2014
Incidence of mucositis in patients treated with temsirolimus-based regimens and correlation to treatment responseXiaochun Liu, Patricia Lorusso, Monica Mita, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 4, 2014
Phase I clinical trial of bendamustine and bevacizumab for patients with advanced cancerApostolia M Tsimberidou, Alexandra M Adamopoulos, Yang Ye, et al.
Journal for Immunotherapy of Cancer|February 10, 2025
TIGIT inhibitor M6223 as monotherapy or in combination with bintrafusp alfa in patients with advanced solid tumors: a first-in-human, phase 1, dose-escalation trialAung Naing, Meredith McKean, Anthony Tolcher, et al.
Pageof 40

Showing results (161-170 of 397) with videos related to

Sort By:
Pageof 40
Investigational New Drugs|January 28, 2020
A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinomaDavid C Smith, Matthias Kroiss, Electron Kebebew, et al.
Cancers|August 23, 2020
Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and ParagangliomasCamilo Jimenez, Vivek Subbiah, Bettzy Stephen, et al.
Journal for Immunotherapy of Cancer|January 17, 2025
Phase I study of BMS-986299, an NLRP3 agonist, as monotherapy and in combination with nivolumab and ipilimumab in patients with advanced solid tumorsBlessie E Nelson, Shaun O'Brien, Rahul A Sheth, et al.
The Oncologist|January 25, 2021
Pembrolizumab in Patients with Advanced Metastatic Germ Cell TumorsApostolia-Maria Tsimberidou, Henry Hiep Vo, Vivek Subbiah, et al.
Oncotarget|June 27, 2013
Revisiting clinical trials using EGFR inhibitor-based regimens in patients with advanced non-small cell lung cancer: a retrospective analysis of an MD Anderson Cancer Center phase I populationJennifer Wheler, Gerald Falchook, Apostolia M Tsimberidou, et al.
Journal of Gastrointestinal Cancer|April 29, 2023
Utility of Established Prognostic Scoring Systems for Patients with Advanced Pancreatic Adenocarcinoma Enrolled in Immunotherapy-Based Early-Phase Clinical TrialsRishi Surana, Graciela Nogueras Gonzalez, Jane Rogers, et al.
Cancers|August 12, 2022
Clinical Outcomes of Patients with Recurrent Microsatellite-Stable Endometrial Cancer in Early-Phase Immunotherapy Clinical TrialsJeffrey A How, Amir A Jazaeri, Siqing Fu, et al.
The Oncologist|March 27, 2014
Incidence of mucositis in patients treated with temsirolimus-based regimens and correlation to treatment responseXiaochun Liu, Patricia Lorusso, Monica Mita, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 4, 2014
Phase I clinical trial of bendamustine and bevacizumab for patients with advanced cancerApostolia M Tsimberidou, Alexandra M Adamopoulos, Yang Ye, et al.
Journal for Immunotherapy of Cancer|February 10, 2025
TIGIT inhibitor M6223 as monotherapy or in combination with bintrafusp alfa in patients with advanced solid tumors: a first-in-human, phase 1, dose-escalation trialAung Naing, Meredith McKean, Anthony Tolcher, et al.
Pageof 40